Victorian aged care residents might be consisted of in the next phase of testing for a possible COVID-19 vaccine that has actually revealed favorable outcomes throughout stage one human trials in Adelaide.
Key points:
- A prospective COVID-19 vaccine developed in Adelaide has actually been shown to be safe and to induce antibodies
- The next phase of trials will consist of elderly patients in aged care houses
- Victorian aged care houses have been the site of numerous devastating break outs
The vaccine prospect, COVAX-19, was developed by Adelaide-based business Vaxine, which has labs at Flinders University.
Volunteers in between the ages of 18 and 65 in Adelaide have been injected with two dosages of either COVAX-19 or a placebo in the stage one trial.
Among the volunteers f